The journal of obstetrics and gynaecology research
-
J. Obstet. Gynaecol. Res. · Jan 2012
Stillbirths in a referral medical college hospital, West Bengal, India: a ten-year review.
To evaluate the stillbirth rate, its major demographic and obstetric risk factors and its trend in a referral teaching hospital. ⋯ Poor antenatal check-up, lower socioeconomic status and weak referral facilities were the major factors responsible for stillbirths. Most of the stillbirths were preventable by improving women's education and compliance to antenatal care. So proper antenatal care, prompt referral services and availability of emergency obstetric care will provide a pivotal role for reduction of stillbirths.
-
J. Obstet. Gynaecol. Res. · Jan 2012
Correlation of magnesium levels in cord blood and maternal serum among pre-eclamptic pregnant women treated with magnesium sulfate.
The aim of this study was to determine the correlation between cord blood and maternal serum magnesium levels among pre-eclamptic pregnant women treated with magnesium sulfate. ⋯ Maternal serum magnesium and calcium levels were correlated with cord blood levels in pre-eclamptic pregnant women who received MgSO4 therapy.
-
J. Obstet. Gynaecol. Res. · Dec 2011
Impact of a single perioperative dose of dexamethasone on the incidence of surgical site infections: a case-control study.
Dexamethasone is recommended in several international guidelines to prevent postoperative nausea and vomiting, a problem especially frequent in gynecological patients. Despite the increasing use of dexamethasone for this indication there are limited data concerning potential harmful effects of corticosteroids in surgical patients, especially the potential negative impact on wound healing and surgical site infection (SSI). This case-control study was conducted to look for potentially harmful effects of a single perioperative dose of dexamethasone with respect to the occurrence of SSI in gynecological and obstetric surgery patients. ⋯ In this case-control study we could not detect any evidence for an increased risk for SSI after a single-dose of dexamethasone (4-8 mg) in gynecological patients.
-
J. Obstet. Gynaecol. Res. · Dec 2011
Case ReportsSecondary postpartum hemorrhage due to uterine artery pseudoaneurysm rupture in von Willebrand disease.
We here report a case of a 33-year-old woman who experienced secondary postpartum hemorrhage (PPH) due to uterine artery pseudoaneurysm rupture. She had intrauterine balloon tamponade for unexplained primary PPH after spontaneous vaginal delivery, and subsequent angiography showed no abnormal contrast extravasation. However, profuse vaginal bleeding occurred 22 days postpartum. ⋯ She was successfully treated with selective uterine arterial embolization. Decreased levels of von Willebrand factor and factor VIII led to the diagnosis of von Willebrand disease. When it is determined that a patient has unexplained PPH or uterine artery pseudoaneurysm, a high index of suspicion and further investigation for underlying bleeding disorders is warranted.
-
J. Obstet. Gynaecol. Res. · Dec 2011
Case ReportsAnti-N-methyl-D-aspartate receptor encephalitis associated with ovarian immature teratoma.
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a treatment-responsive encephalitis associated with anti-NMDAR antibodies. Unlike classic paraneoplastic encephalitis, this disorder usually develops in young women with ovarian teratoma who typically present with marked neuropsychiatric symptoms, followed by prolonged respiratory failure, clouding of consciousness, and bizarre dyskinesia. This disorder is often treatable by resection of ovarian tumor and immunotherapy, but, delayed diagnosis results in a worse condition and sometimes fatal outcome. ⋯ When physicians encounter a female patient with encephalitis showing marked neuropsychiatric symptoms, search for an ovarian tumor should be promptly initiated. We present a case of anti-NMDAR encephalitis associated with ovarian immature teratoma. The symptoms were dramatically relieved by tumor resection and immunotherapy.